
Managed Care Pharmacy Practice
by Navarro, Robert P.-
This Item Qualifies for Free Shipping!*
*Excludes marketplace orders.
Buy New
Buy Used
Rent Textbook
eTextbook
We're Sorry
Not Available
How Marketplace Works:
- This item is offered by an independent seller and not shipped from our warehouse
- Item details like edition and cover design may differ from our description; see seller's comments before ordering.
- Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
- Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
- Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.
Summary
Table of Contents
Contributors | p. xvii |
Foreword | p. xxi |
Preface | p. xxiii |
Acknowledgments | p. xxv |
Fundamentals of Managed Care Pharmacy Benefit Management | p. 1 |
The U.S. Health Care System and the Development of Managed Care | p. 3 |
Introduction to U.S. Health Insurance Industry | p. 4 |
Evolution of the Health Insurance Industry | p. 6 |
Economic Basis for the Development of Managed Care | p. 7 |
Early Development of Managed Care | p. 8 |
HMO Act of 1973 | p. 11 |
Federal and State Growth in Managed Care: Medicare and Medicaid | p. 13 |
MCOs: More than HMOs | p. 14 |
Physician Reimbursement Mechanisms | p. 19 |
Gatekeeper Physicians | p. 22 |
Risk Sharing of Pharmacy Cost | p. 22 |
Carve-Out and Ancillary Health Care Benefits | p. 22 |
Quest for Quality | p. 23 |
Impact of Managed Care on Physicians and Pharmacists | p. 24 |
Member Involvement in Managed Care | p. 26 |
Conclusion | p. 27 |
Pharmacy Benefit Management Principles and Practices | p. 29 |
Basis for Pharmacy Benefit Management | p. 29 |
Principles of Pharmacy Benefit Management | p. 32 |
Growth of PBMs | p. 33 |
Pharmacy Benefit Management Program Components | p. 36 |
Advanced Pharmacy Benefit Management Components | p. 43 |
Measuring Pharmacy Benefit Management Program Performance | p. 43 |
Conclusion | p. 45 |
Pharmacy Benefit Design, Contracting, and Marketing | p. 47 |
Business Basis for Pharmacy Benefit Management | p. 47 |
Corporate and Government Impetus for Pharmacy Benefit Management | p. 49 |
Legal Basis of Pharmacy Benefit Management | p. 50 |
Benefit Design, State Requirements | p. 52 |
Principles of Marketing Pharmacy Benefits | p. 53 |
Payer and Patient Expectations and Decision Points | p. 55 |
Role of Members in Pharmacy Benefit Provider Selection | p. 57 |
Pharmacy Performance Measurements Important in Marketing | p. 59 |
Marketing Campaign Advertisement Examples | p. 60 |
Marketing Process | p. 60 |
Pharmacy Benefit Contracting Components | p. 62 |
Pharmacy Benefit Management Contracting Trends | p. 64 |
Risk Contracting | p. 65 |
Overview of Impact of Medicare and Medicaid | p. 65 |
Risk-Contracting Elements and Executions | p. 68 |
Payer Expectations | p. 70 |
Performance Measurement | p. 72 |
Future Trends in Pharmacy Benefit Design and Contracting | p. 73 |
Conclusion | p. 76 |
Appendix 3-A | p. 77 |
Appendix 3-B | p. 83 |
Pharmacy Distribution Systems and Network Management | p. 89 |
Pharmacy Program Distribution Options | p. 90 |
Community Pharmacy Provider Networks | p. 90 |
Pharmacy Provider Network Development | p. 92 |
Pharmacy Provider Network Contracting | p. 93 |
Participating Pharmacy Provider Agreement | p. 94 |
Participating Pharmacy Provider Manual | p. 95 |
Participating Pharmacy Network Management Issues | p. 95 |
Measuring Performance | p. 97 |
Audits | p. 98 |
Reports | p. 100 |
Member Satisfaction | p. 100 |
In-House Pharmacies | p. 101 |
Mail Service Pharmacy | p. 107 |
Developing an Integrated Distribution System | p. 108 |
Pharmacist's Role | p. 111 |
Impact of Managed Care on the Profession of Pharmacy | p. 114 |
Conclusion | p. 114 |
Appendix 4-A | p. 116 |
Pharmacy Data and Information Systems | p. 125 |
Scope of Pharmacy Information Management | p. 125 |
Pharmacy Information Management Systems | p. 127 |
PMSs and Electronic Data Interchange | p. 134 |
Role of Switching Companies | p. 135 |
Internet Technology | p. 137 |
Adjudication Systems | p. 138 |
Other MCO Information Systems | p. 141 |
Conclusion | p. 143 |
Drug Formulary Management | p. 145 |
History and Purpose of Drug Formularies | p. 145 |
Definitions | p. 147 |
Why Formularies? | p. 148 |
Decision-Making Process | p. 151 |
Formulary Exception Process | p. 157 |
Formularies' Relationship to Other Pharmaceutical Care Practices | p. 158 |
Future Directions | p. 161 |
Conclusion | p. 163 |
Drug Utilization Review Strategies | p. 167 |
History and Current Role of DUE/DUR | p. 167 |
Types of DURs | p. 170 |
Steps in Conducting DURs | p. 173 |
Application of DUR in Pharmacy Benefit Management | p. 175 |
Prior Authorization | p. 176 |
Prospective DUR | p. 178 |
Physician Education Programs | p. 179 |
Performance Measurement of DUR Programs | p. 180 |
Evolution of DUR | p. 181 |
Conclusion | p. 182 |
Member Satisfaction Strategies | p. 185 |
Importance of Member Satisfaction | p. 186 |
National Committee for Quality Assurance and Health Plan Employer Data and Information Set | p. 189 |
Satisfaction Measurement among Employer Groups | p. 191 |
Member Satisfaction with Pharmacy Benefits | p. 192 |
Conclusion | p. 197 |
Pharmacy Program Performance Measurement | p. 199 |
Role of Pharmacy Benefits in Overall Health Plan Performance | p. 199 |
Pharmacy Performance Metrics | p. 200 |
Measuring Performance of Various Components | p. 207 |
Interpreting Results of Pharmacy Measurement | p. 208 |
Interpreting Cost Metrics | p. 208 |
Communication of Pharmacy Program Results | p. 210 |
Application of Results for Program Improvement | p. 212 |
Advanced Outcomes Management Metrics | p. 216 |
Linking Pharmacy Programs to Overall Medical and Economic Outcomes | p. 219 |
Conclusion | p. 220 |
Pharmacy Benefit Management Companies | p. 221 |
Genesis of PBMs | p. 221 |
Growth and Evolution of PBMs | p. 226 |
Outsourcing Pharmacy Benefit Management to a PBM | p. 230 |
Financial Arrangement between PBMs and Their Customers | p. 236 |
Projecting Cost Savings Using PBM Services | p. 237 |
Reintegrating the Value of PBM Services | p. 238 |
Contracting for PBM Services | p. 239 |
Conclusion | p. 240 |
Advanced Pharmacy Benefit Management Strategies | p. 243 |
Medicaid Pharmacy Benefit Management | p. 245 |
Legislative History | p. 245 |
Administration of Medicaid Benefits | p. 247 |
Funding Medicaid Benefits | p. 248 |
Medicaid Eligibility | p. 248 |
Medicaid Services | p. 249 |
Medicaid Benefit Design | p. 250 |
Managed Care Waivers | p. 250 |
Medicaid Managed Care Contracts | p. 251 |
Performance Measures and Member Satisfaction | p. 252 |
Medicaid Pharmacy Benefit Design | p. 252 |
OTC Product Coverage | p. 253 |
Medicaid Prescription Copayments | p. 253 |
Dispensing Fees | p. 254 |
Pharmaceutical Manufacturer Rebates | p. 255 |
Challenges and Opportunities in Medicaid Pharmacy Benefit Management | p. 255 |
Medicaid Demographic Challenges | p. 255 |
Developmental and Cultural Issues | p. 256 |
Traditional Fee-For-Service Medicaid Benefit Management Challenges | p. 257 |
Managed Care Challenges in Providing Medicaid Benefits | p. 259 |
Pharmacy Benefit Management Opportunities | p. 261 |
Future Managed Care Medicaid Trends | p. 264 |
Conclusion | p. 267 |
Medicare Pharmacy Benefit Management | p. 269 |
The Social Security Act of 1965 and the Tax Equity and Fiscal Responsibility Act | p. 269 |
Benefits Covered under Medicare | p. 272 |
Types of Medicare Programs | p. 272 |
Why Medicare Enrollees Prefer HMOs to Traditional Medicare | p. 274 |
Prescription Use and the Medicare Patient | p. 275 |
Management of the Medicare Prescription Drug Benefit | p. 276 |
Location of Network Pharmacies | p. 277 |
Drug Formularies | p. 277 |
Mail Order | p. 280 |
Drug Utilization Review | p. 280 |
The Future of Medicare | p. 281 |
Conclusion | p. 281 |
Quality Improvement Initiatives in Managed Care | p. 285 |
Defining Quality Health Care | p. 285 |
Assigning Accountability | p. 289 |
Measuring Quality | p. 290 |
Current Quality Improvement Initiatives | p. 293 |
NCQA | p. 294 |
Joint Commission | p. 297 |
American Accreditation Healthcare Commission/The Utilization Review Accreditation Commission | p. 302 |
FACCT | p. 303 |
AHCPR | p. 304 |
HCFA | p. 306 |
Other Quality Improvement Initiatives | p. 306 |
Future of Quality Measurement in Managed Care | p. 307 |
Role of Pharmacists | p. 309 |
Conclusion | p. 311 |
Health Informatics Systems | p. 313 |
Evolution of Pharmacy Data Standardization | p. 314 |
EDI and Electronic Commerce | p. 315 |
Data and Information Needs of Managed Care | p. 318 |
Pharmacy and Medical Claims Integration | p. 324 |
Electronic Medical Record Data | p. 328 |
Building a Data Warehouse | p. 332 |
Patient Outcomes Assessment | p. 336 |
Electronic Prescribing | p. 337 |
Merging Retrospective and Transactional Data | p. 340 |
Pharmacy and Health Telematics | p. 341 |
On-Line Patient Marketing | p. 342 |
Conclusion | p. 343 |
Provider and Vendor Risk Contracts | p. 347 |
Pharmacy Risk Contracting | p. 347 |
Physician Risk Contracts | p. 352 |
Reimbursement Agreements | p. 359 |
Choosing a Reimbursement Methodology | p. 364 |
Quality Issues | p. 365 |
Forecast | p. 366 |
Conclusion | p. 368 |
Disease Management Programs | p. 371 |
Definition and Goals | p. 372 |
Rationale | p. 374 |
Medical Conditions Appropriate for Disease Management | p. 375 |
Disease Management Process | p. 376 |
Growth of Disease Management | p. 378 |
Role of Pharmacy Benefit Management Companies | p. 378 |
Pharmaceutical Manufacturer Role in Disease Management | p. 379 |
Role of Physicians in Disease Management | p. 380 |
Role of Pharmacists in Disease Management | p. 382 |
Role and Source of Disease Management Guidelines | p. 386 |
Role of Drug Formularies in Disease Management | p. 388 |
Modifying Participant Behavior | p. 388 |
Barriers to Successful Programs | p. 391 |
Specialty Carve-Out and Carve-In Disease Management Companies | p. 391 |
Measuring Program Performance | p. 392 |
Conclusion | p. 392 |
Pharmacoeconomic Research and Applications in Managed Care | p. 397 |
Basics of Pharmacoeconomic Research | p. 400 |
Application of Pharmacoeconomics in Pharmaceutical Companies | p. 402 |
Use of Pharmacoeconomic Data for Effectiveness Claims | p. 404 |
Role of Pharmacoeconomic Research in Product Management | p. 408 |
Pharmacoeconomic Information Strategies within Pharmaceutical Companies | p. 410 |
Packaging Pharmacoeconomic Data for Use by P and T Committees | p. 413 |
Role of Pharmacoeconomic Data in Evidence-Based Drug Formularies | p. 416 |
Research Opportunities for Managed Care Organizations and PBMs | p. 418 |
Role of Pharmacoeconomics in Decompartmentalizing Plan Management | p. 418 |
Sources of Data | p. 423 |
Opportunities for Pharmacists in Pharmacoeconomic Research and Applications | p. 428 |
Conclusion | p. 429 |
The Role of the Pharmaceutical Industry in Managed Health Care | p. 433 |
Influence of Managed Care on the Sales of Pharmaceuticals | p. 434 |
Relationship of Pharmaceutical Manufacturers to Managed Care | p. 435 |
Evolution of the Pharmaceutical Marketplace | p. 435 |
Managed Care Marketing Strategy Development | p. 442 |
Contractual Relationships between the Pharmaceutical and Managed Care Industries | p. 443 |
Pharmaceutical Company Support Services for Managed Care | p. 445 |
Future Relationship of Pharmaceutical Manufacturers with Managed Care | p. 447 |
Pharmacy Practice Issues in Managed Care | p. 449 |
The Impact of Managed Care on Pharmacy Practice | p. 451 |
Impact of Managed Care Programs on Pharmacy | p. 452 |
Reimbursement for Managed Care Prescriptions | p. 454 |
Administration of Managed Care Prescription Contracts | p. 458 |
Managed Care Strategies for Pharmacists | p. 466 |
Effect of Managed Care on Hospital Pharmacies | p. 470 |
Conclusion | p. 471 |
Pharmaceutical Care in Managed Care | p. 475 |
Current Trends | p. 476 |
Examples of Pharmaceutical Care in Managed Care | p. 480 |
Impact of Pharmaceutical Care in Managed Care: Cost and Quality | p. 488 |
Reimbursement for Pharmaceutical Care: Cognitive Services | p. 490 |
Conclusion | p. 493 |
Pharmacist Career Path Opportunities in Managed Care | p. 497 |
The Future of Pharmacy under Managed Care | p. 497 |
Preparing for a Career in Managed Health Care | p. 499 |
Novel Career Opportunities | p. 501 |
Maintaining Career Viability | p. 501 |
Questions Surrounding an Uncertain Future | p. 502 |
Professional Responsibilities toward Career | p. 504 |
Conclusion | p. 504 |
Ethical Aspects of Pharmacy Practice in Managed Care | p. 507 |
Examples of Ethical Issues and Concerns | p. 508 |
Ethical Values: Their Place in Pharmacy Practice | p. 511 |
Ethical Principles and Concepts in Pharmacy Practice | p. 516 |
Resources for Managing Ethical Concerns in Pharmacy Practice | p. 520 |
Conclusion | p. 523 |
Drug Policy and Regulation in Managed Care | p. 525 |
Food and Drug Administration Issues | p. 525 |
Direct-to-Consumer Advertising | p. 531 |
Patient "Bill of Rights" Initiatives | p. 532 |
Patient Privacy Issues | p. 536 |
Fraud and Abuse and Consumer Protection Legislation | p. 541 |
Therapeutic Interchange | p. 543 |
Narrow Therapeutic Index Drugs | p. 545 |
Employee Retirement Income Security Act | p. 547 |
Licensing | p. 550 |
Any Willing Provider and Freedom of Choice Legislation | p. 551 |
Mail Service Pharmacies | p. 553 |
Conclusion | p. 554 |
International Opportunities for Pharmacists in Managed Care | p. 557 |
Managed Care Techniques | p. 560 |
Austria | p. 562 |
Denmark | p. 562 |
Finland | p. 562 |
France | p. 563 |
Germany | p. 563 |
Italy | p. 563 |
The Netherlands | p. 563 |
Norway | p. 564 |
Sweden | p. 564 |
Switzerland | p. 564 |
United Kingdom | p. 565 |
Career Opportunities Abroad | p. 565 |
Conclusion | p. 567 |
Future of Pharmacy Benefit Management | p. 571 |
Forces of Change | p. 572 |
Reaction and Interaction of Change Forces | p. 574 |
Impact of Forces of Change | p. 575 |
Pharmacy Practice in the Year 2000 and Beyond | p. 589 |
Conclusion | p. 590 |
Glossary | p. 593 |
About the Contributors | p. 625 |
Index | p. 632 |
Table of Contents provided by Syndetics. All Rights Reserved. |
An electronic version of this book is available through VitalSource.
This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.
By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.
A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.
Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.
Please view the compatibility matrix prior to purchase.